HopeStage
Back to all studies
CompletedNCT06854601

Safety and Efficacy of Mexidol® for ADHD in Children Aged 6-12

This study evaluated the safety and effectiveness of Mexidol for people with ADHD.

Medication studyAges 6–12Russia
The study in practice

Understand this study

What did researchers investigate?

This study evaluated the safety and effectiveness of Mexidol for people with ADHD.

Who was this study for?

This study was for people with ADHD. Listed age limits: 6 years to 12 years. Other eligibility criteria applied.

Listed locations
Yekaterinburg and 13 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: July 13, 2019
Recruitment status
Completed
Enrollment listed in the registry
333
Sponsor
Pharmasoft
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Russia
Age range
From 6 Years to 12 Years
Official registry ID
NCT06854601
Official title
Show the full official title

A Multicenter, Double-blind, Randomized, Placebo-controlled Clinical Trial in Three Parallel Groups to Evaluate the Effectiveness and Safety of Mexidol® Film-coated Tablets, 125 mg (LLC 'NPK PHARMASOFT', Russia) in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years With Various Dosing Regimens (MEGA).

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Yekaterinburg, Russia · Kazan', Russia · Krasnodar, Russia

9 more locations
  • Moscow, Russia
  • Nizhny Novgorod, Russia
  • Orenburg, Russia
  • Saint Petersburg, Russia
  • Saratov, Russia
  • Tver', Russia
  • Tyumen, Russia
  • Ulyanovsk, Russia
  • Russia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

This study evaluated the safety and effectiveness of Mexidol for people with ADHD.

Who is behind this study?

The study sponsor is Pharmasoft.

Did this study involve medication?

Yes. The study involved medication, including Mexidol, Placebo and Mexidol + Placebo.

Who was this study for?

This study was for people with ADHD. Listed age limits: 6 years to 12 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies